Calcium channel blocker examples
Pro Research Analysisby 
Searched over 200M research papers
Common Calcium Channel Blocker Examples
Calcium channel blockers (CCBs) are a group of medications that prevent calcium from entering cells of the heart and blood vessel walls, leading to relaxation of blood vessels and reduced heart workload. The most widely used CCBs target L-type calcium channels and are commonly prescribed for conditions like hypertension, angina, and arrhythmias 578.
L-Type Calcium Channel Blockers
The main classes of L-type calcium channel blockers include:
- Dihydropyridines: Examples are amlodipine, nifedipine, felodipine, and nicardipine. These are primarily used for their blood pressure-lowering effects and are among the most frequently prescribed CCBs 578.
- Phenylalkylamines: The most notable example is verapamil, which is often used for heart rate control in arrhythmias 578.
- Benzothiazepines: Diltiazem is the main drug in this class, used for both blood pressure and heart rate control 578.
T-Type Calcium Channel Blockers
T-type calcium channel blockers are less commonly used in clinical practice but are being explored for their potential in treating epilepsy, neuropathic pain, and other neurological conditions. Examples include:
- Ethosuximide: Widely used in the treatment of absence epilepsy due to its action on T-type calcium channels .
- Mibefradil: Previously marketed for selective T-type calcium channel blockade but withdrawn due to safety concerns 16.
- Newer agents: Compounds such as Z944 and ACT-709478 are currently in clinical trials and show promise as selective T-type calcium channel blockers .
N-Type Calcium Channel Blockers
- Ziconotide: A peptide blocker of N-type (CaV2.2) calcium channels, used for severe chronic pain when other treatments have failed .
Other Notable Calcium Channel Blockers
- Gabapentinoids: Drugs like gabapentin and pregabalin target the auxiliary subunit of calcium channels and are used for certain types of epilepsy and chronic neuropathic pain .
- Experimental and Genetically Encoded Blockers: New strategies, such as optogenetic and chemogenetic blockers, are being developed for precise control of calcium channels in research and potential future therapies .
Conclusion
The most common calcium channel blockers in clinical use are dihydropyridines (e.g., amlodipine, nifedipine), phenylalkylamines (verapamil), and benzothiazepines (diltiazem), all of which primarily target L-type calcium channels. Other types, such as ethosuximide and ziconotide, target T-type and N-type channels, respectively, and are used for specific neurological or pain conditions. Ongoing research is expanding the range of available calcium channel blockers, with new agents under development for greater selectivity and fewer side effects 1357+1 MORE.
Sources and full results
Most relevant research papers on this topic